695 related articles for article (PubMed ID: 1690762)
21. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
[TBL] [Abstract][Full Text] [Related]
22. Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions.
Michie SA; Abel EA; Hoppe RT; Warnke RA; Wood GS
J Invest Dermatol; 1989 Jul; 93(1):116-20. PubMed ID: 2473133
[TBL] [Abstract][Full Text] [Related]
23. Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell.
Payne CM; Spier CM; Grogan TM; Richter LC; Bjore CG; Cromey DW; Rangel CS
Am J Dermatopathol; 1988 Oct; 10(5):377-89. PubMed ID: 3265861
[TBL] [Abstract][Full Text] [Related]
24. Patch tests in Sézary syndrome and mycosis fungoides.
Shupp DL; Winkelmann RK
Contact Dermatitis; 1985 Sep; 13(3):180-5. PubMed ID: 4053598
[TBL] [Abstract][Full Text] [Related]
25. Locomotion of T cells from patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides).
Gupta S; Safai B; Edelson R; Parrott D; Good R
Cell Immunol; 1980 Mar; 50(1):195-201. PubMed ID: 6967357
[No Abstract] [Full Text] [Related]
26. Sézary syndrome originates from heavily mutated hematopoietic progenitors.
Harro CM; Sprenger KB; Chaurio RA; Powers JJ; Innamarato P; Anadon CM; Zhang Y; Biswas S; Mandal G; Mine JA; Cortina C; Nagy MZ; Martin AL; Handley KF; Borjas GJ; Chen PL; Pinilla-Ibarz J; Sokol L; Yu X; Conejo-Garcia JR
Blood Adv; 2023 Sep; 7(18):5586-5602. PubMed ID: 37531660
[TBL] [Abstract][Full Text] [Related]
27. [Sézary syndrome. Clinical, immunological and proliferative kinetics].
Marosi L; Hofer F; Schwarzmeier J; Konrad K; Knapp W; Radaskiewicz T
Acta Med Austriaca; 1979; 6(5):237-40. PubMed ID: 318012
[TBL] [Abstract][Full Text] [Related]
28. The significance of Leu 8 negative T cells in lymphoid skin infiltrates: malignant transformation, selective homing or T-cell activation?
Rijlaarsdam JU; Boorsma DM; de Haan P; Sampat S; Willemze R
Br J Dermatol; 1990 Nov; 123(5):587-93. PubMed ID: 2248888
[TBL] [Abstract][Full Text] [Related]
29. Flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides: International guidelines for assay characteristics.
Horna P; Wang SA; Wolniak KL; Psarra K; Almeida J; Illingworth AJ; Johansson U; Craig FE; Torres R
Cytometry B Clin Cytom; 2021 Mar; 100(2):142-155. PubMed ID: 32319723
[TBL] [Abstract][Full Text] [Related]
30. Follicular center helper T-cell (TFH) marker positive mycosis fungoides/Sezary syndrome.
Meyerson HJ; Awadallah A; Pavlidakey P; Cooper K; Honda K; Miedler J
Mod Pathol; 2013 Jan; 26(1):32-43. PubMed ID: 22918164
[TBL] [Abstract][Full Text] [Related]
31. Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides.
Yazıcı S; Bülbül Başkan E; Budak F; Oral B; Adim ŞB; Ceylan Kalin Z; Özkaya G; Aydoğan K; Saricaoğlu H; Tunali Ş
J Immunol Res; 2015; 2015():856340. PubMed ID: 26788525
[TBL] [Abstract][Full Text] [Related]
32. CD7-positive Sézary syndrome with a Th1 cytokine profile.
Yagi H; Tokura Y; Furukawa F; Takigawa M
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):368-74. PubMed ID: 8655729
[TBL] [Abstract][Full Text] [Related]
33. Epidermal Langerhans' cell densities influence survival in mycosis fungoides and Sézary syndrome.
Meissner K; Michaelis K; Rehpenning W; Löning T
Cancer; 1990 May; 65(9):2069-73. PubMed ID: 2196990
[TBL] [Abstract][Full Text] [Related]
34. Poikilodermatous mycosis fungoides and atrophic large-plaque parapsoriasis exhibit similar abnormalities of T-cell antigen expression.
Lindae ML; Abel EA; Hoppe RT; Wood GS
Arch Dermatol; 1988 Mar; 124(3):366-72. PubMed ID: 3257858
[TBL] [Abstract][Full Text] [Related]
35. Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study.
Querfeld C; Thompson JA; Taylor MH; DeSimone JA; Zain JM; Shustov AR; Johns C; McCann S; Lin GHY; Petrova PS; Uger RA; Molloy N; Shou Y; Akilov OE
Lancet Haematol; 2021 Nov; 8(11):e808-e817. PubMed ID: 34627593
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
Edelson RL
J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
[TBL] [Abstract][Full Text] [Related]
37. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome.
Furue M; Kadono T
J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic characterization of CD7+, CD3+, and CD8+ lymphocytes from first trimester human decidua using two-color flow cytometry.
Chernyshov VP; Slukvin II; Bondarenko GI
Am J Reprod Immunol; 1993 Jan; 29(1):5-16. PubMed ID: 7684920
[TBL] [Abstract][Full Text] [Related]
39. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
[TBL] [Abstract][Full Text] [Related]
40. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
